Concepedia

Publication | Open Access

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

DOIFull Paper Access

399

Citations

20

References

2013

Year

Jonathan E. Rosenberg, Richard Bambury, Eliezer M. Van Allen, Harry A. Drabkin, Primo N. Lara, Andrea Harzstark, Nikhil Wagle, Robert A. Figlin, Gregory W. Smith, Levi A. Garraway,
Investigational New Drugs

References

YearCitations

Page 1